Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity.

Uchida, Y; Terada, K; Madokoro, Y; Fujioka, T; Mizuno, M; Toyoda, T; Kato, D; Matsukawa, N

Uchida, Y; Terada, K; Madokoro, Y; Fujioka, T; Mizuno, M; Toyoda, T; Kato, D; Matsukawa, N.

Affiliation

Uchida Y; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Terada K; Department of Epileptology, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
Madokoro Y; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Fujioka T; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Mizuno M; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Toyoda T; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kato D; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Matsukawa N; Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Acta Neurol Scand ; 137(4): 432-437, 2018 Apr.

Article de En | MEDLINE | ID: mdl-29313881

Sujet(s)
Mots clés

antiepileptic drugs; cross-sensitivity; skin rash; status epilepticus; stiripentol

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: État de mal épileptique / Toxidermies / Dioxolanes / Anticonvulsivants Type d'étude: Diagnostic_studies / Observational_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Acta Neurol Scand Année: 2018 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google